NYU Langone Hospital—Long Island announced that it is launching two important COVID-19 vaccine studies and is currently enrolling participants. In the first study, the hospital is enrolling young adults, ages 18 through 29 years, including university students.
This study is part of a nationwide “Prevent COVID U study” to evaluate COVID-19 infection and transmission among young adults. The study, involving the Moderna COVID-19 vaccine, is intended to help determine whether a person can become infected after they’ve been vaccinated and if the vaccine will stop the virus from spreading person-to-person.
Study results are expected to have implications for public health—including on college campuses—especially when new variants are emerging. All participants who have not yet been vaccinated by the end of the four-month study will be offered the Moderna vaccine. The study will also include young adults who choose not to receive a vaccine. Study participants will be compensated approximately $900 for their time and inconvenience.
In the second study, called the “Mix and Match study,” the hospital will assess the safety and effects on the immune system of mixing one type of COVID-19 vaccination with a subsequent booster vaccination of a different type, such as a Johnson & Johnson vaccination followed by a Moderna booster shot or other variant vaccine.
NYU Langone Hospital—Long Island is seeking to enroll previously unvaccinated participants for this study, ages 18 and up, with compensation to participants of approximately $700.
For convenience, many study procedures will be conducted remotely and electronically, such as employing an eDiary app for questionnaires and returning nasal swabs by mail.
The nationwide Prevent COVID U study involves more than 40 sites nationwide and is being conducted through the COVID-19 Prevention Network, operationally headquartered at Fred Hutchinson Cancer Research Center.
These studies are funded by the federal COVID-19 Response Program and the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. The “Mix and Match” study is funded by the Division of Microbiology and Infectious Disease (DMID) of NIAID.
For more information, contact the NYU Long Island Vaccine Center at 516-663-3890 or email: nyuwinthropvaccine@nyulangone.org.
